Suppression of the Deubiquitinating Enzyme USP5 Causes the Accumulation of Unanchored Polyubiquitin and the Activation of p53

Saurabh Dayal, Alison Sparks, Jimmy Jacob, Nerea Allende-Vega, David Lane, Mark K. Saville (Lead / Corresponding author)

    Research output: Contribution to journalArticle

    105 Citations (Scopus)

    Abstract

    Both p53 and its repressor Mdm2 are subject to ubiquitination and proteasomal degradation. We show that knockdown of the deubiquitinating enzyme USP5 (isopeptidase T) results in an increase in the level and transcriptional activity of p53. Suppression of USP5 stabilizes p53, whereas it has little or no effect on the stability of Mdm2. This provides a mechanism for transcriptional activation of p53. USP5 knockdown interferes with the degradation of ubiquitinated p53 rather than attenuating p53 ubiquitination. In vitro studies have shown that a preferred substrate for USP5 is unanchored polyubiquitin. Consistent with this, we observed for the first time in a mammalian system that USP5 makes a major contribution to Lys-48-linked polyubiquitin disassembly and that suppression of USP5 results in the accumulation of unanchored polyubiquitin chains. Ectopic expression of a C-terminal mutant of ubiquitin (G75A/G76A), which also causes the accumulation of free polyubiquitin, recapitulates the effects of USP5 knockdown on the p53 pathway. We propose a model in which p53 is selectively stabilized because the unanchored polyubiquitin that accumulates after USP5 knockdown is able to compete with ubiquitinated p53 but not with Mdm2 for proteasomal recognition. This raises the possibility that there are significant differences in proteasomal recognition of p53 and Mdm2. These differences could be exploited therapeutically. Our study reveals a novel mechanism for regulation of p53 and identifies USP5 as a potential target for p53 activating therapeutic agents for the treatment of cancer.

    Original languageEnglish
    Pages (from-to)5030-5041
    Number of pages12
    JournalJournal of Biological Chemistry
    Volume284
    Issue number8
    DOIs
    Publication statusPublished - 20 Feb 2009

    Keywords

    • UBIQUITIN-PROTEASOME SYSTEM
    • DNA-DAMAGE
    • PROTEIN-DEGRADATION
    • ISOPEPTIDASE-T
    • IN-VIVO
    • CONJUGATING ENZYMES
    • CANCER-CELLS
    • TUMOR-CELLS
    • MDM2
    • CHAINS

    Cite this

    Dayal, Saurabh ; Sparks, Alison ; Jacob, Jimmy ; Allende-Vega, Nerea ; Lane, David ; Saville, Mark K. / Suppression of the Deubiquitinating Enzyme USP5 Causes the Accumulation of Unanchored Polyubiquitin and the Activation of p53. In: Journal of Biological Chemistry. 2009 ; Vol. 284, No. 8. pp. 5030-5041.
    @article{3cadaca8156e4dfca44fdfc95f68d9b1,
    title = "Suppression of the Deubiquitinating Enzyme USP5 Causes the Accumulation of Unanchored Polyubiquitin and the Activation of p53",
    abstract = "Both p53 and its repressor Mdm2 are subject to ubiquitination and proteasomal degradation. We show that knockdown of the deubiquitinating enzyme USP5 (isopeptidase T) results in an increase in the level and transcriptional activity of p53. Suppression of USP5 stabilizes p53, whereas it has little or no effect on the stability of Mdm2. This provides a mechanism for transcriptional activation of p53. USP5 knockdown interferes with the degradation of ubiquitinated p53 rather than attenuating p53 ubiquitination. In vitro studies have shown that a preferred substrate for USP5 is unanchored polyubiquitin. Consistent with this, we observed for the first time in a mammalian system that USP5 makes a major contribution to Lys-48-linked polyubiquitin disassembly and that suppression of USP5 results in the accumulation of unanchored polyubiquitin chains. Ectopic expression of a C-terminal mutant of ubiquitin (G75A/G76A), which also causes the accumulation of free polyubiquitin, recapitulates the effects of USP5 knockdown on the p53 pathway. We propose a model in which p53 is selectively stabilized because the unanchored polyubiquitin that accumulates after USP5 knockdown is able to compete with ubiquitinated p53 but not with Mdm2 for proteasomal recognition. This raises the possibility that there are significant differences in proteasomal recognition of p53 and Mdm2. These differences could be exploited therapeutically. Our study reveals a novel mechanism for regulation of p53 and identifies USP5 as a potential target for p53 activating therapeutic agents for the treatment of cancer.",
    keywords = "UBIQUITIN-PROTEASOME SYSTEM, DNA-DAMAGE, PROTEIN-DEGRADATION, ISOPEPTIDASE-T, IN-VIVO, CONJUGATING ENZYMES, CANCER-CELLS, TUMOR-CELLS, MDM2, CHAINS",
    author = "Saurabh Dayal and Alison Sparks and Jimmy Jacob and Nerea Allende-Vega and David Lane and Saville, {Mark K.}",
    year = "2009",
    month = "2",
    day = "20",
    doi = "10.1074/jbc.M805871200",
    language = "English",
    volume = "284",
    pages = "5030--5041",
    journal = "Journal of Biological Chemistry",
    issn = "0021-9258",
    publisher = "American Society for Biochemistry and Molecular Biology",
    number = "8",

    }

    Suppression of the Deubiquitinating Enzyme USP5 Causes the Accumulation of Unanchored Polyubiquitin and the Activation of p53. / Dayal, Saurabh; Sparks, Alison; Jacob, Jimmy; Allende-Vega, Nerea; Lane, David; Saville, Mark K. (Lead / Corresponding author).

    In: Journal of Biological Chemistry, Vol. 284, No. 8, 20.02.2009, p. 5030-5041.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Suppression of the Deubiquitinating Enzyme USP5 Causes the Accumulation of Unanchored Polyubiquitin and the Activation of p53

    AU - Dayal, Saurabh

    AU - Sparks, Alison

    AU - Jacob, Jimmy

    AU - Allende-Vega, Nerea

    AU - Lane, David

    AU - Saville, Mark K.

    PY - 2009/2/20

    Y1 - 2009/2/20

    N2 - Both p53 and its repressor Mdm2 are subject to ubiquitination and proteasomal degradation. We show that knockdown of the deubiquitinating enzyme USP5 (isopeptidase T) results in an increase in the level and transcriptional activity of p53. Suppression of USP5 stabilizes p53, whereas it has little or no effect on the stability of Mdm2. This provides a mechanism for transcriptional activation of p53. USP5 knockdown interferes with the degradation of ubiquitinated p53 rather than attenuating p53 ubiquitination. In vitro studies have shown that a preferred substrate for USP5 is unanchored polyubiquitin. Consistent with this, we observed for the first time in a mammalian system that USP5 makes a major contribution to Lys-48-linked polyubiquitin disassembly and that suppression of USP5 results in the accumulation of unanchored polyubiquitin chains. Ectopic expression of a C-terminal mutant of ubiquitin (G75A/G76A), which also causes the accumulation of free polyubiquitin, recapitulates the effects of USP5 knockdown on the p53 pathway. We propose a model in which p53 is selectively stabilized because the unanchored polyubiquitin that accumulates after USP5 knockdown is able to compete with ubiquitinated p53 but not with Mdm2 for proteasomal recognition. This raises the possibility that there are significant differences in proteasomal recognition of p53 and Mdm2. These differences could be exploited therapeutically. Our study reveals a novel mechanism for regulation of p53 and identifies USP5 as a potential target for p53 activating therapeutic agents for the treatment of cancer.

    AB - Both p53 and its repressor Mdm2 are subject to ubiquitination and proteasomal degradation. We show that knockdown of the deubiquitinating enzyme USP5 (isopeptidase T) results in an increase in the level and transcriptional activity of p53. Suppression of USP5 stabilizes p53, whereas it has little or no effect on the stability of Mdm2. This provides a mechanism for transcriptional activation of p53. USP5 knockdown interferes with the degradation of ubiquitinated p53 rather than attenuating p53 ubiquitination. In vitro studies have shown that a preferred substrate for USP5 is unanchored polyubiquitin. Consistent with this, we observed for the first time in a mammalian system that USP5 makes a major contribution to Lys-48-linked polyubiquitin disassembly and that suppression of USP5 results in the accumulation of unanchored polyubiquitin chains. Ectopic expression of a C-terminal mutant of ubiquitin (G75A/G76A), which also causes the accumulation of free polyubiquitin, recapitulates the effects of USP5 knockdown on the p53 pathway. We propose a model in which p53 is selectively stabilized because the unanchored polyubiquitin that accumulates after USP5 knockdown is able to compete with ubiquitinated p53 but not with Mdm2 for proteasomal recognition. This raises the possibility that there are significant differences in proteasomal recognition of p53 and Mdm2. These differences could be exploited therapeutically. Our study reveals a novel mechanism for regulation of p53 and identifies USP5 as a potential target for p53 activating therapeutic agents for the treatment of cancer.

    KW - UBIQUITIN-PROTEASOME SYSTEM

    KW - DNA-DAMAGE

    KW - PROTEIN-DEGRADATION

    KW - ISOPEPTIDASE-T

    KW - IN-VIVO

    KW - CONJUGATING ENZYMES

    KW - CANCER-CELLS

    KW - TUMOR-CELLS

    KW - MDM2

    KW - CHAINS

    UR - http://www.scopus.com/inward/record.url?scp=64149087218&partnerID=8YFLogxK

    U2 - 10.1074/jbc.M805871200

    DO - 10.1074/jbc.M805871200

    M3 - Article

    VL - 284

    SP - 5030

    EP - 5041

    JO - Journal of Biological Chemistry

    JF - Journal of Biological Chemistry

    SN - 0021-9258

    IS - 8

    ER -